The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Abstract
Lymphocyte-specific interferon regulatory factor (LSIRF) (now called IRF4) is a transcription factor expressed only in lymphocytes. Mice deficient in IRF4 showed normal distribution of B and T lymphocyes at 4 to 5 weeks of age but developed progressive generalized lymphadenopathy. IRF4-deficient mice exhibited a profound reduction in serum immunoglobulin concentrations and did not mount detectable antibody responses. T lymphocyte function was also impaired in vivo; these mice could not generate cytotoxic or antitumor responses. Thus, IRF4 is essential for the function and homeostasis of both mature B and mature T lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pip-deficient animals develop normal numbers of B cells (including λ-expressors) which cannot undergo activation”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Mittrucker et al., 1997
In the citing paper
“whereas PIP function is necessary for maturation of B and T lymphocytes (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“whereas PIP−/− animals exhibit a block in peripheral maturation of B cells and fail to produce antibodies in response to antigenic stimulation.”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“Similarly, T cells of the mutant animals (PIP−/−) lack proliferative and cytotoxic responses (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
Citations
Cites
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A. C., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,258
Self-citationInterleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. I., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,079
Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages
Kamijo, R., Harada, H., Matsuyama, T., Bosland, M. C., Gerecitano, J. F., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) · Science · doi:10.1126/science.7510419 · Cited by 843
Self-citationTanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Self-citationPip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 431
Self-citationBetz, A. G., Milstein, C., González‐Fernández, Á., Pannell, R., Larson, T., & Neuberger, M. S. (1994) · Cell · doi:10.1016/0092-8674(94)90316-6 · Cited by 379
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
石原, 正. (1997) · Cited by 366
Transitional B cells are the target of negative selection in the B cell compartment.
Carsetti, R., Köhler, G., & Lamers, M. C. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2129 · Cited by 358
Interferon-Induced Antiviral Actions and Their Regulation
Sen, G. C., & Ransohoff, R. M. (1993) · Advances in virus research · doi:10.1016/s0065-3527(08)60083-4 · Cited by 334
Research works printed but not linked: 4
- Lamphier M., Taniguchi T., Immunologist 2, 167 (1994);
- Vaughan P. S., et al., ibid. 377, 362 (1995);
- Schmits R., et al., ibid., p. 1415.
- Healthy 5- to 7-week-old mice were used for all experiments. Mice were maintained according to the guidelines of the Canadian Council of Animal Care. H.-W.M. is a recipient of a grant from the Deutsche Forschungsgemeinschaft. The authors thank M. Bachmann G. Boehmelt G. Duncan D. Ferrick C. Furlonger D. Kägi F. Kiefer L. Marengere C. Paige J. Penninger M. Saunders R. Schmits D. Siderovski D. Speiser S. Yoshinaga and P. Waterhouse for providing reagents and for helpful comments.
Cited by
Sorted by citations
Items 301–400 of 583
Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases
Kim, S. J. (2015) · Immunologic Research · doi:10.1007/s12026-015-8694-5 · Cited by 35
Factors Regulating Immunoglobulin Production by Normal and Disease-Associated Plasma Cells
Jackson, D., & Elsawa, S. F. (2015) · Biomolecules · doi:10.3390/biom5010020 · Cited by 40
Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis
Martínez, M. R., Corradin, A., Klein, U., Alvarez, M. J., TOFFOLO, G. M., Camillo, B. D., Califano, A., & Stolovitzky, G. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113019109 · Cited by 39
Wang, X., Su, W., Gao, Y., Feng, Y., Wang, X., Chen, X., Hu, Y., Ma, Y., Ou, Q., Liang, D., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.279908 · Cited by 37
IRF4 as an Oncogenic Master Transcription Factor
Wong, R. W. J., Ong, J. Z. L., Theardy, M. S., & Sanda, T. (2022) · Cancers · doi:10.3390/cancers14174314 · Cited by 39
Enhanced TCR-induced Apoptosis in Interferon Regulatory Factor 4–deficient CD4+ Th Cells
Lohoff, M. D., Mittrücker, H., Brüstle, A., Sommer, F. O., Casper, B., Huber, M., Ferrick, D. A., Duncan, G. S., & Mak, T. W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040182 · Cited by 36
Self-citationIRF-4-Mediated CIITA Transcription Is Blocked by KSHV Encoded LANA to Inhibit MHC II Presentation
Cai, Q., Banerjee, S., Cervini, A., Lu, J. L., Hislop, A. D., Dzeng, R. K., & Robertson, E. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003751 · Cited by 35
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas
Bandini, C., Pupuleku, A., Spaccarotella, E., Pellegrino, E., Wang, R., Vitale, N., Duval, C., Cantarella, D., Rinaldi, A., Provero, P., et al. (2018) · Cancers · doi:10.3390/cancers10010021 · Cited by 36
Patterson, D. G., Kania, A. K., Price, M. J., Rose, J. R., Scharer, C. D., & Boss, J. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100440 · Cited by 35
Interferon Regulatory Factor 4 Contributes to Transformation of v-Rel-Expressing Fibroblasts
Hrdličková, R., Nehyba, J., & Bose, H. R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6369-6386.2001 · Cited by 35
Repression of IRF-4 target genes in human T cell leukemia virus-1 infection
Mamane, Y., Grandvaux, N., Hernandez, E., Sharma, S., Innocente, S. A., Lee, J. M., Azimi, N., Lin, R., & Hiscott, J. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205843 · Cited by 35
Regulation of T helper cell differentiation by interferon regulatory factor family members
Zhang, R., Chen, K., Peng, L., & Xiong, H. (2012) · Immunologic Research · doi:10.1007/s12026-012-8328-0 · Cited by 33
Targeting CK2-driven non-oncogene addiction in B-cell tumors
Mandato, E., Manni, S., Zaffino, F., Semenzato, G., & Piazza, F. (2016) · Oncogene · doi:10.1038/onc.2016.86 · Cited by 35
Lee, M.-C., Lacey, D. C., Fleetwood, A. J., Achuthan, A. A., Hamilton, J. A., & Cook, A. D. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801549 · Cited by 34
Kojima, Y., Tsurumi, H., Goto, N., Shimizu, M., Kasahara, S., Yamada, T., Kanemura, N., Hara, T., Sawada, M., Saio, M., et al. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00631.x · Cited by 34
Klein, M., Brühl, T.-J., Staudt, V., Reuter, S., Grebe, N., Gerlitzki, B., Hoffmann, M., Bohn, T., Ulges, A., Stergiou, N., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401823 · Cited by 33
The gene regulatory network controlling plasma cell function
Trezise, S., & Nutt, S. L. (2021) · Immunological Reviews · doi:10.1111/imr.12988 · Cited by 33
Gene Expression Profiles Define a Key Checkpoint for Type 1 Diabetes in NOD Mice
Eckenrode, S., Ruan, Q., Yang, P. C., Zheng, W., McIndoe, R., & She, J. (2004) · Diabetes · doi:10.2337/diabetes.53.2.366 · Cited by 33
Lu, C., Li, S., Qing, P., Zhang, Q., Ji, X., Tang, Z., Chen, C., Wu, T., Hu, Y., Zhao, Y., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167602 · Cited by 32
Innate Antiviral Response: Role in HIV-1 Infection
Pitha, P. M. (2011) · Viruses · doi:10.3390/v3071179 · Cited by 34
Kudo, C., Yamakoshi, H., Sato, A., Ohori, H., Ishioka, C., Iwabuchi, Y., & Shibata, H. (2011) · PubMed · Cited by 32
Zhang, F., Rincón, M., Flavell, R. A., & Aune, T. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1762 · Cited by 31
Pavan, A., Spina, M., Canzonieri, V., Sansonno, S., Toffoli, G., & Re, V. D. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802444176 · Cited by 31
García‐Morato, M. B., Santos, F. J. A., Briones, A. C., Moreno, A. B., del Pozo, Á., Domínguez‐Soto, Á., Merino, M. J. B., Molina, L. D. P., Torres, J. M., Marín, A. V., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.995 · Cited by 31
A Role for Interferon Regulatory Factor 4 in Receptor Editing
Pathak, S., Ma, S., Trinh, L., & Lu, R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01946-07 · Cited by 33
Refaat, A., Zhou, Y., Suzuki, S., Takasaki, I., Koizumi, K., Yamaoka, S., Tabuchi, Y., Saiki, I., & Sakurai, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200907 · Cited by 31
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ‘unmutated’ B-CLL
Michaux, L., Wlodarska, I., Rack, K. A., Stul, M. S., Criel, A. M., Maerevoet, M., Marichal, S., Demuynck, H., Mineur, P., Kargar-Samani, K., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403543 · Cited by 31
Lückerath, K., Kirkin, V., Melzer, I. M., Thalheimer, F. B., Siele, D., Milani, W., Adler, T., Aguilar‐Pimentel, J. A., Horsch, M., Michel, G., et al. (2010) · Blood · doi:10.1182/blood-2010-07-292722 · Cited by 31
Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma
Gualco, G., Queiroga, E., Weiss, L. M., Klumb, C. E., Harrington, W. J., & Bacchi, C. E. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.07.021 · Cited by 31
Regulation of Lymphocyte Apoptosis by Interferon Regulatory Factor 4 (IRF-4)
Fanzo, J., Hu, C.-M., Jang, S. Y., & Pernis, A. B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020717 · Cited by 31
Chromatin Protein PC4 Orchestrates B Cell Differentiation by Collaborating with IKAROS and IRF4
Ochiai, K., Yamaoka, M., Swaminathan, A., Shima, H., Hiura, H., Matsumoto, M., Kurotaki, D., Nakabayashi, J., Funayama, R., Nakayama, K., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108517 · Cited by 29
Tang, T. F., Chan, Y. T., Cheong, H. C., Cheok, Y. Y., Anuar, N. A., Looi, C. Y., Gan, G. G., & Wong, W. F. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104594 · Cited by 29
The biology and cytogenetics of multiple myeloma.
Ho, P., Campbell, L., Gibson, J., Brown, R. D., & Joshua, D. (2002) · Reviews in Clinical and Experimental Hematology · doi:10.1046/j.1468-0734.2002.00081.x · Cited by 26
Ito, M., Iida, S., Inagaki, H., Tsuboi, K., Komatsu, H., Yamaguchi, M., Nakamura, N., Suzuki, R., Seto, M., Nakamura, S., et al. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01307.x · Cited by 30
Implication of IRF4 Aberrant Gene Expression in the Acute Leukemias of Childhood
Adamaki, M., Lambrou, G. Ι., Athanasiadou, A., Tzanoudaki, M., Vlahopoulos, S., & Moschovi, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072326 · Cited by 28
JunB Is Critical for Survival of T Helper Cells
Hsieh, T.-H., Sasaki, D., Taira, N., Chien, H.-C., Sarkar, S., Seto, Y., Miyagi, M., & Ishikawa, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.901030 · Cited by 29
Uranishi, M., Iida, S., Sanda, T., Ishida, T., Tajima, E., Ito, M., Komatsu, H., Inagaki, H., & Ueda, R. (2005) · Leukemia · doi:10.1038/sj.leu.2403833 · Cited by 29
Imaizumi, Y., Kohno, T., Yamada, Y., Ikeda, S., Tanaka, Y., Tomonaga, M., & Matsuyama, T. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02151.x · Cited by 29
Self-citationSteimle‐Grauer, S. A., Tinguely, M., Seada, L., Fellbaum, C., & Hansmann, M. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-002-0735-5 · Cited by 29
The role of Irf6 in tooth epithelial invagination
Blackburn, J., Ohazama, A., Kawasaki, K., Otsuka‐Tanaka, Y., Liu, B., Honda, K., Rountree, R. B., Hu, Y., Kawasaki, M., Birchmeier, W., et al. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.02.009 · Cited by 28
Review: IRF-4 Activities in HTLV-I-Induced T Cell Leukemogenesis
Mamane, Y., Sharma, S., Grandvaux, N., Hernandez, E., & Hiscott, J. B. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452746 · Cited by 28
Id2 represses E2A-mediated activation of IL-10 expression in T cells
Masson, F., Ghisi, M., Groom, J. R., Kallies, A., Seillet, C., Johnstone, R. W., Nutt, S. L., & Belz, G. T. (2014) · Blood · doi:10.1182/blood-2014-03-561456 · Cited by 27
Crucial Role of Increased Arid3a at the Pre-B and Immature B Cell Stages for B1a Cell Generation
Hayakawa, K., Li, Y., Shinton, S. A., Bandi, S. R., Formica, A. M., Brill‐Dashoff, J., & Hardy, R. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00457 · Cited by 27
Continuous Expression of Interferon Regulatory Factor 4 Sustains CD8 + T Cell Immunity against Tumor
Yu, A., Fu, J., Yin, Z. Q., Yan, H. M., Xiao, X., Zou, D., Zhang, X., Zu, X., Li, X. C., & Chen, W. (2023) · Research · doi:10.34133/research.0271 · Cited by 28
DEVELOPMENTAL BIOLOGY OF HEMATOPOIESIS
Evans, T. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70485-8 · Cited by 28
Rybicki, B. A., MALIARIK, M. J., Malvitz, E., Sheffer, R., Major, M. L., Popovich, J., & Iannuzzi, M. C. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00050-6 · Cited by 28
Function and dysfunction of plasma cells in intestine
Wang, X., Hao, G., Wang, B., Gao, C., Wang, Y.-X., Li, L.-S., & Xu, J. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0288-9 · Cited by 28
Cook, S. L., Franke, M. C., Sievert, E. P., & Sciammas, R. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.05.001 · Cited by 26
Pine, R. I. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452629 · Cited by 25
Anti-CD23 monoclonal antibody inhibits germline Cε transcription in B cells
Shingo, Y., Nakamura, T., Kloetzer, W. S., & Reff, M. E. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00187-4 · Cited by 26
Transcriptional Control of Pre-B Cell Development and Leukemia Prevention
Pang, S. H. M., Carotta, S., & Nutt, S. L. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_377 · Cited by 28
Factors That Regulate the Generation of Antibody-Secreting Plasma Cells
Yu, Y.-H., & Lin, K. (2016) · Advances in immunology · doi:10.1016/bs.ai.2016.03.001 · Cited by 26
Tissue-Specific Diversity and Functions of Conventional Dendritic Cells
Pakalniškytė, D., & Schraml, B. U. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.01.003 · Cited by 27
Gupta, S. K., Xia, D., Jiang, M., Lee, S.-J., & Pernis, A. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5997 · Cited by 23
Parks, R., Kim, C. J., Al-Safi, Z. A., Armstrong, A. A., Zore, T., & Moatamed, N. A. (2018) · International Journal of Surgical Pathology · doi:10.1177/1066896918814307 · Cited by 23
Asslaber, D., Qi, Y., Maeding, N., Steiner, M. J., Denk, U., Höpner, J. P., Hartmann, T. N., Zaborsky, N., Greil, R., & Egle, A. (2019) · Blood · doi:10.1182/blood.2019000973 · Cited by 24
Ma, S., Shukla, V., Fang, L., Gould, K. A., Joshi, S. S., & Lu, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.475913 · Cited by 24
Regulation pattern of fish irf4 (the gene encoding IFN regulatory factor 4) by STAT6, c-Rel and IRF4
Li, S., Guo, X., Lu, L.-F., Lu, X.-B., Wu, N., & Zhang, Y. (2015) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2015.02.018 · Cited by 24
Immune gene discovery by expressed sequence tag analysis of spleen in the duck (Anas platyrhynchos)
Xia, J., Radford, C., GUO, X., & Magor, K. E. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2006.06.005 · Cited by 24
The Proto-Oncogene c-myc Regulates Antibody Secretion and Ig Class Switch Recombination
Fernández‐Antorán, D., Ortiz, M., Rodríguez, L., García, A. R., Martínez, D., & de Alborán, I. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300712 · Cited by 26
Interactions Between NK Cells and B Lymphocytes
Yuan, D. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)84001-x · Cited by 24
Matsumoto, M., Hisatake, K., Nogi, Y., & Tsujimoto, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104299200 · Cited by 24
Active repression of IFN regulatory factor-1-mediated transactivation by IFN regulatory factor-4
Yoshida, K., Yamamoto, K., Kohno, T., Hironaka, N., Yasui, K., Kojima, C., Mukae, H., Kadota, J., Suzuki, S., Honma, K., et al. (2005) · International Immunology · doi:10.1093/intimm/dxh324 · Cited by 26
Self-citationFrantz, G. D., Pham, T. Q., Peale, F. V., Jr., & Hillan, K. J. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200109)195:1 · Cited by 27
Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma
Dunleavy, K. M., Grant, C. M., & Wilson, W. H. (2012) · Therapeutic Advances in Hematology · doi:10.1177/2040620712464508 · Cited by 23
A limited number of genes are involved in the differentiation of germinal center B cells
Nakayama, Y., Stabach, P. R., Maher, S. E., Mahajan, M. C., Masiar, P., Liao, C. L., Zhang, X., Ye, Z., Tuck, D. P., Bothwell, A. L. M., et al. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20952 · Cited by 23
Gene Interaction Network Regulates Plasma Cell Differentiation
Alinikula, J., & Lassila, O. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02556.x · Cited by 26
Drug Resistance in Diffuse Large B-Cell Lymphoma
Wilson, W. H. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.07.005 · Cited by 23
Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors
Bretz, J., García, J., Huang, X., Kang, L., Zhang, Y., Toellner, K., & Chen‐Kiang, S. (2010) · Blood · doi:10.1182/blood-2010-06-288027 · Cited by 23
Chiu, Y., Wang, L., Lu, T., Hsiao, T.-H., Chuang, E. Y.-Y., & Chen, Y. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1557-4 · Cited by 22
IFN Regulatory Factor 4 Controls Post-ischemic Inflammation and Prevents Chronic Kidney Disease
Lorenz, G., Moschovaki-Filippidou, F., Würf, V., Metzger, P., Steiger, S., Batz, F., Carbajo-Lozoya, J., Kozieł, J., Schnurr, M. M., Cohen, C. D., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02162 · Cited by 22
IFI16Expression Is Related to Selected Transcription Factors during B-Cell Differentiation
Piccaluga, P. P., Agostinelli, C., Fuligni, F., Righi, S., Tripodo, C., Re, M. C., Clò, A., Miserocchi, A., Morini, S., Gariglio, M., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/747645 · Cited by 24
Plasma Cell Formation, Secretion, and Persistence: The Short and the Long of It
Bayles, I., & Milcarek, C. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014012168 · Cited by 23
Critical Functions of IRF4 in B and T Lymphocytes
Hagman, J. R. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701385 · Cited by 22
Role of complement in a murine model of peanut-induced anaphylaxis
Kodama, T., Sekine, H., Takahashi, M., Iwaki, D., Machida, T., Kanno, K., Ishida, Y., Endo, Y., & Fujita, T. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.10.003 · Cited by 22
Uncovering MicroRNA Regulatory Hubs that Modulate Plasma Cell Differentiation
Tsai, D.-Y., Hung, K.-H., Lin, I., Su, S., Wu, S.-Y., Chung, C., Wang, T.-C., Li, W., Shih, A. C.-C., & Lin, K. (2015) · Scientific Reports · doi:10.1038/srep17957 · Cited by 21
Li, W., Nagineni, C. N., Efiok, B. J. S., Chepelinsky, A. B., & Egwuagu, C. E. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9267 · Cited by 21
Xiong, Z., Zhang, W., Liu, S., Liu, K., Wang, J., Qin, P., Liu, Y., & Jiang, Q. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13671 · Cited by 20
Kaku, H., & Rothstein, T. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901988 · Cited by 20
IFN-? limitin: a member of type I IFN with mild lympho-myelosuppression
Oritani, K., & Kanakura, Y. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00353.x · Cited by 21
Regulation of Telomerase Activity by Interferon Regulatory Factors 4 and 8 in Immune Cells
Hrdličková, R., Nehyba, J., & Bose, H. R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00961-08 · Cited by 20
Nagulapalli, S., Goheer, A., Pitt, L. K., McIntosh, L. P., & Atchison, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7337-7350.2002 · Cited by 20
Molecular interactions of IRF4 in B cell development and malignancies
Sundararaj, S., & Casarotto, M. G. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00825-6 · Cited by 19
Dendritic cell functions in vivo: A user's guide to current and next‐ generation mutant mouse models
Dalod, M., & Scheu, S. (2022) · European Journal of Immunology · doi:10.1002/eji.202149513 · Cited by 19
Roy, K., Chakraborty, M., Kumar, A., Manna, A. K., & Roy, N. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1185597 · Cited by 22
Role for interferon regulatory factors in autoimmunity
Richez, C., Barnetche, T., Miceli‐Richard, C., Blanco, P., Moreau, J., Rifkin, I. R., & Schaeverbeke, T. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.08.005 · Cited by 19
Chen, Q., Mosovsky, K. L., & Ross, A. C. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.05.003 · Cited by 19
Eikmans, M., Waanders, M. M., Roelen, D. L., van Miert, P. P. M. C., Anholts, J., de Fijter, H. W., Brand, A., & Claas, F. H. J. (2010) · Transplantation · doi:10.1097/tp.0b013e3181fa943d · Cited by 19
New Transcription Factors in Diagnostic Hematopathology
Ponzoni, M., Arrigoni, G., & Doglioni, C. (2006) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31802f0495 · Cited by 19
Continuous Culture of Mouse Primary B Lymphocytes by Forced Expression of Bach2
Finney, J., & Kelsoe, G. H. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100172 · Cited by 18
Arnold, P. R., Wen, M., Zhang, L., Ying, Y., Xiao, X., Chu, X., Wang, G., Zhang, X., Mao, Z., Zhang, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.966364 · Cited by 16
The transcription factor IRF4 determines the anti-tumor immunity of CD8+ T cells
Yan, H., Dai, Y., Zhang, X., Zhang, H., Xiao, X., Fu, J., Zou, D., Yu, A., Jiang, T., Li, X. C., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108087 · Cited by 17
Targeting transcription factors in multiple myeloma: evolving therapeutic strategies
Li, S., Vallet, S., Sacco, A., Roccaro, A. M., Lentzsch, S., & Podar, K. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1605354 · Cited by 18
Perini, T., Materozzi, M., & Milan, E. (2021) · FEBS Journal · doi:10.1111/febs.16068 · Cited by 18
Interferon regulatory factor 4 regulates thymocyte differentiation by repressing Runx3 expression
Cao, Y., Li, H., Sun, Y., Chen, X., Liu, H., Gao, X., & Liu, X. (2010) · European Journal of Immunology · doi:10.1002/eji.201040570 · Cited by 20
Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future
Brown, J. R. (2013) · Therapeutic Advances in Hematology · doi:10.1177/2040620713495639 · Cited by 20
Carlsson, R., Persson, C., & Leanderson, T. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00032-4 · Cited by 18
Can autoimmune disease be cured by deep CD19+ cell depletion?
Suan, D., Moore, J., & Goodnow, C. C. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf008 · Cited by 18
The Role of B Cells in PE Pathophysiology: A Potential Target for Perinatal Cell-Based Therapy?
Magatti, M., Masserdotti, A., Cargnoni, A., Papait, A., Stefani, F. R., Silini, A. R., & Parolini, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073405 · Cited by 17
Thouenon, R., Chentout, L., Moreno-Corona, N. C., Poggi, L., Lombardi, E. P., Hoareau‐Coudert, B., Schmitt, Y., Lagresle‐Peyrou, C., Bustamante, J. C., André‐Schmutz, I., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221292 · Cited by 17
Metadata
- Authors
- Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W.
- Affiliations
- University of Toronto (CA)
- Nagasaki University (JP)
- B. Patterson, Department of Oncologic Pathology, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, M5G 2C1, Canada.
- Venue
- Science
- Published
- 1997-01-24
- Volume
- 275
- Issue
- 5299
- Pages
- 540-543
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2022687427
- Cited by
- 583
- References
- 21
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 12 · 2023: 20 · 2022: 23 · 2021: 23 · 2020: 17 · 2019: 15 · 2018: 16 · 2017: 20 · 2016: 15 · 2015: 18 · 2014: 25 · 2013: 32 · 2012: 20
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- IRF4, transcription factors, B cells, T cells, lymphocyte homeostasis, lymphadenopathy, antibody deficiency, antibody response, cytotoxic T lymphocytes, antitumor immunity
- MeSH terms
- Lymphadenopathy, Interferon Regulatory Factor-4, Animals, Antibody Formation, B-Lymphocytes, Cell Differentiation, Cells, Cultured, Homeostasis, Mice, Inbred BALB C, T-Lymphocytes, Cytotoxic, Transcription, Genetic, Mice, SCID, Mice, Knockout, Cell Proliferation, Interferon Regulatory Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review